This initial loss comes from reduced appetite, lower calorie intake, and improved blood sugar stability rather than from the dose being at peak strength
It plays a key role in transporting fatty acids into the mitochondria, which are the energy-producing centers of your cells
The OSDI was administered at baseline (pre-treatment) and during follow-up at 1 week, 1 month, and 3 months
Tirzepatide & Semaglutide Tirzepatide and semaglutide often cause gastrointestinal side effects, which are typical for incretin mimetics
La semaglutide, quando assunta in associazione a sulfaniluree o a insulina, aumenta il rischio di ipoglicemia che, a sua volta, pu causare diminuzione della concentrazione
Journal Esteves A, Teixeira da Silva F, Carvalho J, Felgueiras P, Laranjeira P